CN106074717A - A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof - Google Patents

A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof Download PDF

Info

Publication number
CN106074717A
CN106074717A CN201610602037.0A CN201610602037A CN106074717A CN 106074717 A CN106074717 A CN 106074717A CN 201610602037 A CN201610602037 A CN 201610602037A CN 106074717 A CN106074717 A CN 106074717A
Authority
CN
China
Prior art keywords
nasal cavity
parts
essential oils
antiinflammatory
allantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610602037.0A
Other languages
Chinese (zh)
Inventor
隋丽梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610602037.0A priority Critical patent/CN106074717A/en
Publication of CN106074717A publication Critical patent/CN106074717A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of nasal cavity antiinflammatory conditioning liquid, composed of the following components: active ionized calcium, sea salt, Borneolum Syntheticum, olive face cream, lithium magnesium silicate, Myrrha essential oils, sweet basil essential oils, tea tree quintessence oil, powder of Radix Puerariae, allantoin, citric acid.Nasal cavity antiinflammatory cleanout fluid of the present invention is without hormone, ephedrine, antibiotic in raw material, the most comfortable, without any irritative response with posterula.Can effective eliminating bacteria Propagation Methods, rash of detoxifying, can effectively repair nasal cavity minute blood vessel, improve nasal cavity microcirculation, the flat inflammation of quick sterilization, make Rhinitis Symptoms rapid regression.Without any zest, without chemical sterilization composition, nonalcoholic colourless transparent liquid, various raw material phase interworkings and, reach the effect of nasal cavity cleaning, antiinflammatory；Meanwhile, preparation method of the present invention is simple, but the order of addition of considered critical raw material, make cleanout fluid reach optimal effect.

Description

A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof
Technical field
The present invention relates to antiinflammatory cleaning supplies technical field, particularly to a kind of nasal cavity antiinflammatory conditioning liquid and preparation side thereof Method.
Background technology
Nose is a marvelous organ on our health, and all kinds of rhinitis meet powder with treatment Allergic Rhinitis one Dirt, animal skin, pollen, blow the anaphylactogens such as air-conditioning cold wind, with regard to seriality sneeze, rhinocnesmus, have a stuffy nose, flow thin nasal discharge, vexed with ear, People's chronic rhinitis patient's long-term intermittent of tinnitus or alternately have a stuffy nose, causes dizziness, has a strong impact on sleep, work and learn Practising, viscous purulence nasal mucus often blows back into pharyngeal cavity, cough, excessive phlegm occurs.Hypertrophic rhinitis patient's severe nasal blockage, opens face for a long time and exhales Inhale, cause dry laryngopharynx, feel sick, retch, always have foreign body sensation, a hyposmia.Patients with chronic sinusitis nasal cavity always has pus consistence to divide Secretion, causes nasal continuous to be had a stuffy nose, and causes that dizziness, absentminded, attention are unwisely, does not concentrates, hypomnesis. The rhinitis medicine of medicamentous rhinitis patient's life-time service various injury nasal mucosa or laser, operation, cause nasal continuous to be had a stuffy nose, Often epistaxis.Atrophic rhinitis's patient respiratory stench, nasal secretion, in block, socket shape pus crusts, are difficult to blow out, firmly scratch When going out dry crusts, there is a small amount of epistaxis.Take for flu initial stage patients with rhinitis's weather turn cool after, play spray continuously after getting up morning Sneeze, runny nose, easily have a stuffy nose when the temperature difference is big, be mistaken for flu and at will have some coldrex, cause the state of an illness all to increase every day.Similar Rhinitis Symptoms has a variety of, and the kind according to rhinitis is different, and Rhinitis Symptoms is the most different, and Rhinitis Symptoms mainly has nasal obstruction, stream The headache of tears, sneeze, rhinitis type, giddy etc..
Chronic rhinitis is common frequently-occurring disease, acute rhinitis develop.With merge antibacterial secondary infection, treatment the most thorough The end, is relevant with recurrent exerbation, and treatment typically takes heat-clearing and toxic substances removing medicine, and intranasal drips 1% ephedrine liquid, takes sulphonamides or antibiotic, Medicamentous rhinitis is the result of the long-term continuous action of inappropriate nasal cavity applied medicine, it is possible to be not understood as a kind of chronic rhinitis.It causes Cause of disease is because being exactly inappropriate nasal cavity applied medicine, and the nasal mucosa vessels strong including use effect shrinks nasal drop, liquor strength mistake Isotonic medicinal liquid high, non-, over administration or long-term prescription etc..These all can damage the structure of Nasal mucociliary, thus affect nose and glue The physiological function of film, produces clinical disease, if not as good as treatment, the harm of rhinitis can be more serious, and the nasopharyngeal carcinoma of about ninety percent is Because rhinitis obstinate deteriorates caused.
At present, although nasal cavity cleaning health care generally uses normal saline can play as abluent preferably cleans effect Really, but it acts on during nasal cavity the gentleest, and during use, the sense of discomfort of human body is relatively strong, accordingly, it would be desirable to exploitation one is suitable for Nasal cavity environment conditioning liquid for cleaning, the pathogenic bacterium that both can have been assembled by nasal cavity and dirt are discharged, and can reach again bacteriostasis, The a large amount of anaphylactogens assembled in removing nasal cavity even nasal sinuses and antibacterial, virus and pus tears.
Summary of the invention
For problems of the prior art, the present invention provides a kind of nasal cavity antiinflammatory conditioning liquid.
Technical scheme is as follows:
A kind of nasal cavity antiinflammatory conditioning liquid, it is characterised in that be made up of according to weight fraction following components:
Active ionized calcium 10-35 part, sea salt 3-9 part, Borneolum Syntheticum 1-3 part, olive face cream 5-15 part, lithium magnesium silicate 0.5-3 part, do not have Medicine essential oils 3.5-11 part, sweet basil essential oils 1-5 part, tea tree quintessence oil 1-5 part, powder of Radix Puerariae 1-5 part, allantoin 1-5 part, Chinese holly Rafter acid 1-3 part.
Preparation method specifically comprises the following steps that
(1) sea salt is added in 100ml deionized water to dissolving completely；Borneolum Syntheticum adds 10ml medical alcohol to dissolving completely Standby；At ambient temperature, lithium magnesium silicate is added in 300ml deionized water；
(2) being dissolved in by active ionized calcium in 200ml deionized water, uniform stirring, to all dissolving, is sequentially added into Pueraria lobota afterwards Root powder, olive face cream, allantoin, uniform stirring, add liquid prepared by step (1), mix homogeneously；
(3) 25 minutes are stood, after removing bubble, evacuation 0.1mmHg deaeration；Then Myrrha essential oils, sweet basil are added Essential oils and tea tree quintessence oil, stir 15 minutes, static a moment；
(4) citric acid, static 24h are added.
1, active ionized calcium is water-soluble active powder, meets water and i.e. dissolves, and it mainly comprises five kinds of main hot spring level alkalescence Mineral, exists with ionic forms: calcium ion (Ca2+), magnesium ion (Mg2+), potassium ion (K+), sodium ion (Na+), germanium ion (Ge2+), easily it is absorbed by the body.Active ion calcium powder: use the raw materials such as natural Margarita, Corallium Japonicum Kishinouye, Achates, Concha Ostreae, should With high-tech ion exchange and calcining rich in calcium, magnesium, potassium, sodium, manganese, the preparation of germanium ion, based on calcium ion.Calcium The calcining heat of ion typically all has toxin expelling, hyperoxia, alkalescence, activity at 1,400 1800 degree. alkalescence can bacteria growing inhibiting, Especially at antioxidation, anti-inflammatory, sterilize, sterilize, promote epidermis blood circulation, get rid of toxin, and then improve human body from outside to inside Metabolism human body acid poison higher time, cell will face death and cause inflammation phenomenon, or injured cell faces extremely Die, and wound infection antibacterial etc., all will cause inflammation phenomenon, owing to calcium ion can neutralize acid poison, active cell, and make thin Bacterium cannot survive, and inflammation phenomenon therefore can be made to rapidly disappear, and China marine site is vast, has abundant living marine resources, and it produces Technique is simple, and raw material sources are extensive, thus popularizing application prospect is wide.
2 lithium magnesium silicates: this product is silicate mineral material, have nano microcrystalline structure.In water, dispersion forms transparence Thixotropy colloid, dispersed particle size size about 20-50 nanometer.Inorganic substances, not by antibacterial and heated mechanical failure by shear Decomposing, will not will not be gone mouldy by microbial attack, viscosity does not varies with temperature, and can be hydrated with ionized water at normal temperatures, expand For suspension colloid, good weatherability.When concentration is 1.5-2.5%, forms transparent or semitransparent thixotropy gel, eliminate heating Operation, energy-saving convenient.
3 citric acid:
Chemical composition: citric acid is a kind of tricarboxylic acids compounds, and therefore and to other carboxylic acids have similar physics and Chemical property.When being heated to 175 DEG C, it can decompose generation carbon dioxide and water, remains some white crystals.Citric acid is a kind of Stronger organic acid, has 3 H+ to ionize；Heating can resolve into multi-products, reacts with acid, alkali, glycerol etc..
Effect and pharmacology: sterilize, promote infiltration, adjustment vascular permeability
4 allantoin protection mucosal tissues, promote hyperplasia；
Since ancient times, " salt " is just brought the representative articles for use as " clean " to 5 pure sea salt, and Exposure to Sunlight sea salt is except containing chlorination Outside sodium, also keep abundant mineral composition, such as magnesium chloride, calcium sulfate, magnesium sulfate etc..Because inside of human body has phase with sea water As composition, static(al) between human body skin and antibacterial can be made to attract to be short-circuited, micro-electricity that its sodium ion and chloride ion are carried Lotus can produce interference, makes antibacterial be difficult to adhere to survive in the skin surface of people, makes antibacterial be dehydrated, and destroy antibacterial and obtain from skin Take the ability of nutrient, thus kill antibacterial.Use Exposure to Sunlight sea salt to cure the disease, many groups of order can be solved and cure disease at a loss what to do, energy Work miracle, make obstinate disease all kinds of diseases and ailments be eradicated.
6 powder of Radix Puerariae, Radix Puerariae total flavones and puerarin can significantly expand intranasal coronary artery, and can directly relax protection blood vessel Smooth muscle.
7 Borneolum Syntheticums are the processed goods of Spore density Borneolum Syntheticum, and its composition contains dextro Borneolum Syntheticum humulene, beta-elemene, stone Bamboo alkene etc..This product acrid in the mouth, cold in nature, there are logical all keys, dissipate stagnated fire, detumescence removing nebula etc. acts on.In beauty treatment side with make heat-clearing and fire-dispersing, Warding off the product that dirtyization is turbid, for because of heat in blood, interior-heat pents up the treatment of the diseases such as caused halitosis, bromhidrosis, skin infection furuncle.
8 sweet basil: can eliminate the polyp on nasal mucosa, help to reply the olfactory sensation lost because of nasal inflammation, infection. For the malaise symptoms of upper respiratory tract, as thoracic cavity infection, asthma, bronchitis, emphysema, influenza, pertussis with And congestion of nasal sinus, spend the patient's condition such as normal disease to have the effect releived and treat.
9 olive face creams have the effect of stimulating immune system, have extraordinary effect for treatment thoracic cavity infection, are particularly suitable for Chronic bronchitis and the disease of abundant expectoration, moreover it is possible to releive nose larynx mucositis and sinusitis etc., the best results sucked with steam, and And it is of value to the respiratory system of strengthening health.
10 Myrrhas can treat thoracic cavity infection, nose larynx mucositis, chronic bronchitis, pharyngolaryngitis, cough, sore throat and flu Etc. symptom.To oral ulcer, leakage pus, various focusing depths represented, the treatment of the problems such as halitosis is the best
11 tea tree quintessence oils, the original inhabitants in Australia are known that the benefit of tea, also its habit of life-time service a long time ago Used.When World War II, Camellia sinensis is to be sent to the army of torrid areas and ammunition plant for treating the indispensability of skin injury Good medicine, may be used for treating nose larynx mucositis, sinusitis, lymph infectious monocytosis, tonsil, herpes labialis, herpes zoster and candidiasis etc. Antibacterial infects.
Lithium magnesium silicate buying and Guangzhou Bo Feng Chemical Co., Ltd., product batch number 37220-90-9
Olive face cream goods number: RMNAV, Myrrha essential oils goods number: ECO_FR, sweet basil essential oils goods number: EOW_BH, Camellia sinensis essence goods number: EORTT China oil is purchased in Xiang Yuan Asia company limited
Nasal cavity antiinflammatory cleanout fluid of the present invention, without hormone, ephedrine, antibiotic in raw material, the most comfortable with posterula, nothing Any irritative response.Can effective eliminating bacteria Propagation Methods, rash of detoxifying, can effectively repair nasal cavity minute blood vessel, Improve nasal cavity microcirculation, the flat inflammation of quick sterilization, make Rhinitis Symptoms rapid regression.Without any zest, without chemical sterilization composition, no Alcoholic colourless transparent liquid, various raw material phase interworkings and, reach the effect of nasal cavity cleaning, antiinflammatory；Meanwhile, prepared by the present invention Method is simple, but the order of addition of considered critical raw material, make cleanout fluid reach optimal effect.
Detailed description of the invention
Following example are used for illustrating the present invention, but are not limited to the scope of the present invention.Without departing substantially from present invention spirit In the case of essence, the amendment that the inventive method, step or condition are made or replacement, belong to the protection model of the present invention Enclose.
If not specializing, the conventional means that technological means used in embodiment is well known to those skilled in the art.
A kind of nasal cavity antiinflammatory conditioning liquid, is made up of according to weight following components:
Active ionized calcium 10g, sea salt 3g, Borneolum Syntheticum 1g, olive face cream 5g, lithium magnesium silicate 0.5g, Myrrha essential oils 3.5g, sweet sieve Strangle essential oils 1g, tea tree quintessence oil 1g, powder of Radix Puerariae 1g, allantoin 1g, citric acid 1g.
Preparation method, specifically comprises the following steps that
(1) sea salt is added in 100ml deionized water to dissolving completely；Borneolum Syntheticum adds the medical alcohol of 10ml to the most molten Change standby；At ambient temperature, lithium magnesium silicate is added in 300ml deionized water；
(2) being dissolved in the deionized water of 200ml by active ionized calcium, uniform stirring, to all dissolving, is sequentially added into afterwards Powder of Radix Puerariae, olive face cream, allantoin, uniform stirring, add liquid prepared by step (1), mix homogeneously；
(3) 25 minutes are stood, after removing bubble, evacuation 0.1mmHg deaeration；Then Myrrha essential oils, sweet basil are added Essential oils and tea tree quintessence oil, stir 15 minutes, static a moment；
(4) citric acid, static 24h are added.
Embodiment 2
A kind of nasal cavity antiinflammatory conditioning liquid, is made up of according to weight following components:
Active ionized calcium 20g, sea salt 6g, Borneolum Syntheticum 2g, olive face cream 10g, lithium magnesium silicate 1.5g, Myrrha essential oils 8g, sweet sieve Strangle essential oils 3g, tea tree quintessence oil 3g, powder of Radix Puerariae 3g, allantoin 3g, citric acid 2g.
Preparation method is same as in Example 1.
Embodiment 3
A kind of nasal cavity antiinflammatory conditioning liquid, is made up of according to weight following components:
Active ionized calcium 35g, sea salt 9g, Borneolum Syntheticum 3g, olive face cream 15g, lithium magnesium silicate 3g, Myrrha essential oils 11g, sweet basil Essential oils 5g, tea tree quintessence oil 5g, powder of Radix Puerariae 5g, allantoin 5g, citric acid 3g.
Preparation method is same as in Example 1.
Using method:
Lavation, rinses, and instils, the method for any entrance nasal cavities such as spray, three times a day, can be used for improving acute, chronic, Nasal cavity symptom that drying property, atrophic, allergic rhinitis, sinusitis cause and the cleaning of nasal cavity postoperative wound surface, recover nasal cavity merit Energy.
Nose cola nasal-cavity cleaner (nursing device) can be used to be carried out, manufacturer: Jiangsu TechWorld Medicals Co., Ltd. Authentication code: Soviet Union's tool note accurate 20162640003
Tang, man, 25 years old, during senior middle school, cause chronic rhinitis because of repeated cold, have been used up antibiotic, antiallergic, ephedrine The Drug therapys such as nasal drop, effect is undesirable, shortly recurrent exerbation after drug withdrawal.The cleanout fluid using the present invention in 2015, even Continuous use 20 days, cures, does not recurs so far.
Fourth, female, 23 years old, suffer from chronic simple rhinitis 4 years, turbid nasal discharge, nose thiophene, hyposmia, particularly in spring and autumn It is more easy to outbreak season, once used multi-medicament treatment, poor effect, in December, 2014, and used cleanout fluid of the present invention 25 days, symptom All disappear, recovery from illness.
The embodiment above is the embodiment that the present invention is optimal, but embodiment of the present invention are not by above-mentioned embodiment party The restriction of case, other any under conditions of the principle of the invention, can be real by changing produced by the form of parameter Execute example, within being all contained in protection scope of the present invention.

Claims (4)

1. a nasal cavity antiinflammatory conditioning liquid, it is characterised in that composed of the following components:
Active ionized calcium, sea salt, Borneolum Syntheticum, olive face cream, lithium magnesium silicate, Myrrha essential oils, sweet basil essential oils, tea tree quintessence oil, Powder of Radix Puerariae, allantoin, citric acid.
Nasal cavity antiinflammatory conditioning liquid the most according to claim 1, it is characterised in that be made up of according to weight fraction following components:
Active ionized calcium 10-35 part, sea salt 3-9 part, Borneolum Syntheticum 1-3 part, olive face cream 5-15 part, lithium magnesium silicate 0.5-3 part, do not have YAOJING China's oil 3.5-11 part, sweet basil essential oils 1-5 part, tea tree quintessence oil 1-5 part, powder of Radix Puerariae 1-5 part, allantoin 1-5 part, citric acid 1-3 part.
Nasal cavity antiinflammatory conditioning liquid the most according to claim 2, it is characterised in that be made up of according to weight fraction following components:
Active ionized calcium 20 parts, 6 parts of sea salt, Borneolum Syntheticum 2 parts, olive face cream 10 parts, lithium magnesium silicate 1.5 parts, Myrrha essential oils 8 parts are sweet Herba Ocimi (Herba Ocimi Pilosi) essential oils 3 parts, tea tree quintessence oil 3 parts, powder of Radix Puerariae 3 parts, allantoin 3 parts, citric acid 2 parts.
4. the preparation method according to the nasal nursing liquid described in any one of claim 1-3, it is characterised in that concrete steps As follows:
(1) sea salt is added in 100ml deionized water to dissolving completely；It is standby to dissolving completely that Borneolum Syntheticum adds 10ml medical alcohol With；At ambient temperature, lithium magnesium silicate is added in 300ml deionized water；
(2) active ionized calcium is dissolved in 200ml deionized water, uniform stirring to all dissolving, be sequentially added into afterwards powder of Radix Puerariae, Olive face cream, allantoin, uniform stirring, add liquid prepared by step (1), mix homogeneously；
(3) 25 minutes are stood, after removing bubble, evacuation 0.1mmHg deaeration；Then Myrrha essential oils, sweet basil elite are added Oil and tea tree quintessence oil, stir 15 minutes, static a moment；
(4) citric acid, static 24h are added.
CN201610602037.0A 2016-07-28 2016-07-28 A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof Pending CN106074717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610602037.0A CN106074717A (en) 2016-07-28 2016-07-28 A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610602037.0A CN106074717A (en) 2016-07-28 2016-07-28 A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106074717A true CN106074717A (en) 2016-11-09

Family

ID=57450521

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610602037.0A Pending CN106074717A (en) 2016-07-28 2016-07-28 A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106074717A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107812068A (en) * 2017-10-31 2018-03-20 浙江大学医学院附属邵逸夫医院 Formula powder and solution based on a kind of tea extract

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1565435A (en) * 2003-06-26 2005-01-19 联合基因科技有限公司 Nasal cavity nursing solution
CN102988231A (en) * 2012-11-15 2013-03-27 隋丽梅 Feminine care solution and preparation method thereof
CN103120703A (en) * 2013-01-06 2013-05-29 王峥 Care solution for cleaning nasal cavity and related composition
CN103830128A (en) * 2012-11-21 2014-06-04 苏州鑫贝瑞药业有限公司 Novel care solution and applications thereof
CN104367507A (en) * 2014-11-13 2015-02-25 青岛厚科信息工程有限公司 Skincare solution and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1565435A (en) * 2003-06-26 2005-01-19 联合基因科技有限公司 Nasal cavity nursing solution
CN102988231A (en) * 2012-11-15 2013-03-27 隋丽梅 Feminine care solution and preparation method thereof
CN103830128A (en) * 2012-11-21 2014-06-04 苏州鑫贝瑞药业有限公司 Novel care solution and applications thereof
CN103120703A (en) * 2013-01-06 2013-05-29 王峥 Care solution for cleaning nasal cavity and related composition
CN104367507A (en) * 2014-11-13 2015-02-25 青岛厚科信息工程有限公司 Skincare solution and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张卫明等主编: "《芳香疗法和芳香植物》", 31 August 2009, 南京：东南大学出版社 *
胡小勤等主编: "《中药学》", 31 January 2014, 西安：西安交通大学出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107812068A (en) * 2017-10-31 2018-03-20 浙江大学医学院附属邵逸夫医院 Formula powder and solution based on a kind of tea extract

Similar Documents

Publication Publication Date Title
CN106581148A (en) Nasal irrigation care solution
CN101189017A (en) Method of using oxidative reductive potential water solution in dental applications
CN103721286A (en) Air freshener with disinfection function
CN106580817A (en) Antibacterial hand sanitizer based on titanium dioxide/activated carbon composite material
CN103875735A (en) Air sterilizing agent and preparation method thereof
CN108371191A (en) A kind of air antiseptic and its preparation method and application
CN102861206A (en) Sterilizing and disinfecting aerosol for skin mucous membrane and preparation method thereof
CN106074717A (en) A kind of nasal cavity antiinflammatory conditioning liquid and preparation method thereof
CN106075231A (en) Lv Yuan nurses one's health draft film
CN105232415A (en) Geranium essential oil floral water and preparation method thereof
CN103432551B (en) Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia
CN107929428A (en) A kind of composition and its application for oral cavity
CN103784620A (en) Traditional Chinese medicine for treating pulmonary abscess and preparation method thereof
CN105194003A (en) Disinfectant used for cleaning up wounds
CN105380844A (en) Neroli essential oil floral water and preparation method thereof
CN106592323A (en) Preparation method of hemorrhoids-preventing toilet paper
CN105687021A (en) Foot powder for preventing tinea pedis
CN104523493A (en) Toner with lavender fragrance and preparation method of toner
CN106109319A (en) A kind of oral nursing liquid and preparation method thereof
CN101028383A (en) Oral Chinese medicinal composition for treating acute nasosinusitis
WO2022115069A2 (en) Nasal solution with antiviral effect with its ph value
CN101612300A (en) A kind of Chinese drugs agentia for the treatment of the atrophic rhinitis
CN105287296A (en) Chamomile essential oil floral water and preparation method thereof
CN104922449A (en) Traditional Chinese medicine disinfection solution and preparation method thereof
CN104523494A (en) Dendrobium officinale and lavender toner and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161109

RJ01 Rejection of invention patent application after publication